The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis

Anti-tumor activities of active ingredients in Compound Kushen Injection

(2015) Wei Wang et al.   ACTA PHARMACOLOGICA SINICA

Antiviral Natural Products Against Chronic Hepatitis B: Recent Developments

(2015) Mohammad K. Parvez et al.   CURRENT PHARMACEUTICAL DESIGN

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design

(2014) J. M. Llovet et al.   CLINICAL CANCER RESEARCH

Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis

(2014) Lei Liu et al.   PLoS One

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials

(2013) Fan Cheung et al.   Evidence-based Complementary and Alternative Medicine

Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia

(2013) Shukui Qin et al.   JOURNAL OF CLINICAL ONCOLOGY

Antitumor Activities of Kushen: Literature Review

(2012) Mingyu Sun et al.   Evidence-based Complementary and Alternative Medicine

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

(2012) Hashem B. El-Serag   GASTROENTEROLOGY

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

(2012) Joong-Won Park et al.   JOURNAL OF HEPATOLOGY

Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”

(2012) E. Terzi et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Antioxidant and Immunity Activities of Fufang Kushen Injection Liquid

(2012) Shen-Kang Zhou et al.   MOLECULES

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma

(2011) R. Cabrera et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

(2011) Masatoshi Kudo et al.   EUROPEAN JOURNAL OF CANCER

Effects of Matrine on Proliferation and Apoptosis in Gallbladder Carcinoma Cells (GBC-SD)

(2011) Zhiping Zhang et al.   PHYTOTHERAPY RESEARCH

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness

(2008) Adriana Sergio et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Anticancer Effects of the Chinese Medicine Matrine on Murine Hepatocellular Carcinoma Cells

(2008) Lingdi Ma et al.   PLANTA MEDICA